USA Change Macroaxis User Registration

Home Portfolios Solutions About Us

More ROI Blog

PortfoliosPositionsRebalanceAnalyzeOptimize Suggest Industries

US Market Closed: Feb 9, 18:23 PM 2012

NYSE 8081.25 1.73 Index Moved Down

NASDAQ 2927.23 11.37 Index Moved Up

and more..

sponsered by

Processing
Collecting necessary data for ACUR and ARDM...

Asset Comparison and Correlation

View All Portfolios

More Actions
- Select Assests
- Optimize Portfolio
- Suggest Portfolio
- Backtest Watchlist
- Analyze Correlations
- View Transactions
- Check Volatilities
- Import Equities
- Search Equities
- Filter Tops

Acura Pharmaceuticals Inc. and

Aradigm Corp

Volatility

Matrix

Run Correlation

Diversification

Significant diversification

Overlapping area represents amount of risk that can be diversified away by holding Acura Pharmaceuticals Inc. and Aradigm Corp in the same portfolio (assuming nothing else is changed)

Optimize

Correlation Coefficient

0.01

Parameters

Time Period	1 Month [change]
Direction	Positive
Strength	Insignificant
Accuracy	95.45%
Values	Daily Returns

Suggest

Acura Pharmaceuticals Inc.

Profile

3.24

Intraday

One Month

^0.01

0.31%

ACUR

NCM

Acura Pharmaceuticals Inc.

P/E	16.91	Day Low	3.20
Open	3.26	P/B Ratio	3.85
Market Cap	146.8M	Volume	65479
Sector	Healthcare	Last Close	3.23
Short Ratio	27.30	Last Traded	2/9/2012
Year High	6.80	Percent Change	0.31%
EBITDA	9.6M	Year Low	2.28
Absolute Change	0.01	Time	Not Applicable
Book Value	0.838	EPS	0.191
Day High	3.31	Industry	Drug Delivery
Target Price	8.00	Current EPS	0.191
Current PE	16.91	This Year PE	Not Applicable

Aradigm Corp

Profile

0.13

Intraday

One Month

^(0.00)

3.70%

ARDM

OTCBB

Aradigm Corp

Day Low	0.13	Open	0.13
P/B Ratio	11.25	Market Cap	25.7M
Volume	78038	Sector	Healthcare
Last Close	0.135	Founded	Yes
Last Traded	2/9/2012	Year High	Not Applicable
Percent Change	3.70%	EBITDA	-9.9M
Absolute Change	0.00	Time	Not Applicable
Book Value	0.012	EPS	-0.051
Employees	12	Day High	0.131
Target Price	0.83	Current EPS	-0.051
This Year EPS	-0.06	Next Year EPS	-0.06